MCS Medical Compression Systems

MCS Medical Compression Systems is an Israeli medical device company that specializes in the development and manufacturing of non-invasive, portable compression therapy systems. Its flagship product line, ActiveCare, utilizes Synchronized Flow Therapy (SFT) to prevent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in high-risk patients, particularly those undergoing orthopedic surgery. The technology is designed to be portable and battery-operated, allowing for continuous venous blood flow enhancement even when patients are mobile. By providing a mechanical alternative or adjunct to pharmacological anticoagulants, MCS improves patient safety and recovery outcomes. The company was acquired by Zimmer Biomet in 2017 to integrate its compression technology into a broader suite of musculoskeletal healthcare solutions. This acquisition allowed Zimmer Biomet to offer a more comprehensive post-operative care package to its surgical customers.